U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07518810) titled 'Efficacy and Safety of Butylphthalide in the Treatment of Multiple System Atrophy' on March 26.
Brief Summary: The present study aims to conduct a randomized controlled trial to evaluate the efficacy and safety of 3-n-Butylphthalide (NBP) in improving symptoms in patients with Multiple System Atrophy (MSA). The main questions it aims to answer are:
1. To evaluate whether NBP soft capsules, compared with placebo, alleviates the major clinical symptoms in patients with MSA.
2. Whether NBP application is safe to treat patients with MSA. In this trial, NBP will be compared with placebo (similar soft capsule without effective componen...